![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Arena Pharmaceuticals' Stock Sale Opposed
Arena Pharmaceuticals' Stock Sale Opposed
A move by Arena Pharmaceuticals to issue up to 6.9 million shares of company
stock to the public has met stiff opposition from a key shareholder worried
that the sale will dilute the value of the stock. Arena recently announced it
was offering the additional shares on the heels of a lucrative licensing deal
with a Johnson & Johnson subsidiary that could net $295 million in milestone
payments and royalties for Arena.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct